• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

呼吸困难与 COPD 发生率、心脏事件和全因死亡率:从中年到整个生命的 44 年随访。

Breathlessness and incidence of COPD, cardiac events and all-cause mortality: A 44-year follow-up from middle age throughout life.

机构信息

Lund University, Faculty of Medicine, Department of Clinical Sciences Lund, Respiratory Medicine and Allergology, Lund, Sweden.

Dept of Clinical Sciences Malmö, Lund University, Malmö, Sweden.

出版信息

PLoS One. 2019 Mar 18;14(3):e0214083. doi: 10.1371/journal.pone.0214083. eCollection 2019.

DOI:10.1371/journal.pone.0214083
PMID:30883602
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6422305/
Abstract

BACKGROUND

Breathlessness is prevalent in the general population and may be associated with adverse health outcomes. This study aimed to evaluate the association of breathlessness with Chronic Obstructive Pulmonary Disease (COPD) events, cardiac events and all-cause mortality from middle-age throughout life.

METHODS

Breathlessness was measured in 699, 55-year old men residing in Malmö, Sweden using modified Medical Research Council (mMRC). COPD events (hospitalisation, death or diagnosis) cardiac events and all-cause mortality was assessed using The Swedish Causes of Death Register and Hospital Discharge Register. Data was analyzed using Cox- and competing risks (Fine-Gray) regression analysis.

RESULTS

695 (99%) of 699 participants died and four emigrated during follow up. Eighty-seven (12%) had mMRC = 1 and 19 (3%) had mMRC≥2. Breathlessness was associated with COPD events; adjusted Sub-Hazard Ratio 2.1 (95% CI, 1.2-3.6) for mMRC = 1 and 7.5 (2.6-21.7) for mMRC ≥ 2 but not associated with cardiac events when adjusting for competing events and confounding. Breathlessness was associated increased all- cause mortality (Hazard Ratios of 1.4 (1.1-1.7) (mMRC = 1) and 3.4 (2.1-5.6) (mMRC ≥ 2)).

CONCLUSION

Breathlessness is associated with increased risk of COPD events and increase in all-cause mortality from age 55 until death.

摘要

背景

呼吸困难在普通人群中很常见,可能与不良健康结果有关。本研究旨在评估呼吸困难与慢性阻塞性肺疾病(COPD)事件、心脏事件以及从中年到生命结束的全因死亡率之间的关系。

方法

在瑞典马尔默,使用改良版医学研究委员会(mMRC)量表对 699 名 55 岁男性进行呼吸困难测量。使用瑞典死因登记处和住院记录登记处评估 COPD 事件(住院、死亡或诊断)、心脏事件和全因死亡率。使用 Cox 和竞争风险(Fine-Gray)回归分析进行数据分析。

结果

699 名参与者中,有 695 人(99%)在随访期间死亡,4 人移民。87 人(12%)的 mMRC=1,19 人(3%)的 mMRC≥2。呼吸困难与 COPD 事件相关;调整竞争事件和混杂因素后,mMRC=1 的调整后的亚危险比为 2.1(95%CI,1.2-3.6),mMRC≥2 的为 7.5(2.6-21.7)。但与心脏事件无关。呼吸困难与全因死亡率增加相关(mMRC=1 的危险比为 1.4(1.1-1.7),mMRC≥2 的为 3.4(2.1-5.6))。

结论

呼吸困难与 COPD 事件风险增加以及 55 岁至死亡期间全因死亡率增加相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c010/6422305/9642ca7fb48c/pone.0214083.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c010/6422305/ed080d2dd84b/pone.0214083.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c010/6422305/8029cd31b7dc/pone.0214083.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c010/6422305/9642ca7fb48c/pone.0214083.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c010/6422305/ed080d2dd84b/pone.0214083.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c010/6422305/8029cd31b7dc/pone.0214083.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c010/6422305/9642ca7fb48c/pone.0214083.g003.jpg

相似文献

1
Breathlessness and incidence of COPD, cardiac events and all-cause mortality: A 44-year follow-up from middle age throughout life.呼吸困难与 COPD 发生率、心脏事件和全因死亡率:从中年到整个生命的 44 年随访。
PLoS One. 2019 Mar 18;14(3):e0214083. doi: 10.1371/journal.pone.0214083. eCollection 2019.
2
Persistent disabling breathlessness in chronic obstructive pulmonary disease.慢性阻塞性肺疾病中持续存在的致残性呼吸困难。
Int J Chron Obstruct Pulmon Dis. 2016 Nov 9;11:2805-2812. doi: 10.2147/COPD.S119992. eCollection 2016.
3
Effect of Sustained-Release Morphine for Refractory Breathlessness in Chronic Obstructive Pulmonary Disease on Health Status: A Randomized Clinical Trial.持续释放吗啡治疗慢性阻塞性肺疾病难治性呼吸困难对健康状况的影响:一项随机临床试验。
JAMA Intern Med. 2020 Oct 1;180(10):1306-1314. doi: 10.1001/jamainternmed.2020.3134.
4
Influence of comorbid heart disease on dyspnea and health status in patients with COPD - a cohort study.合并心脏病对慢性阻塞性肺疾病患者呼吸困难及健康状况的影响——一项队列研究
Int J Chron Obstruct Pulmon Dis. 2018 Nov 28;13:3857-3865. doi: 10.2147/COPD.S175641. eCollection 2018.
5
Differences in physical activity according to mMRC grade in patients with COPD.慢性阻塞性肺疾病(COPD)患者中,根据医学研究委员会(mMRC)分级的体力活动差异。
Int J Chron Obstruct Pulmon Dis. 2016 Sep 13;11:2203-2208. doi: 10.2147/COPD.S109694. eCollection 2016.
6
Validation of the Dyspnea Exertion Scale of Breathlessness in People With Life-Limiting Illness.呼吸困难费力量表在生命终末期患者中的验证。
J Pain Symptom Manage. 2018 Sep;56(3):430-435.e2. doi: 10.1016/j.jpainsymman.2018.05.002. Epub 2018 May 10.
7
Differential Effect of Modified Medical Research Council Dyspnea, COPD Assessment Test, and Clinical COPD Questionnaire for Symptoms Evaluation Within the New GOLD Staging and Mortality in COPD.改良医学研究委员会呼吸困难量表、慢性阻塞性肺疾病评估测试及临床慢性阻塞性肺疾病问卷在慢性阻塞性肺疾病新全球倡议分期及死亡率中对症状评估的差异效应
Chest. 2015 Jul;148(1):159-168. doi: 10.1378/chest.14-2449.
8
Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease.改良医学研究委员会量表与基线呼吸困难指数用于评估慢性阻塞性肺疾病中的呼吸困难
Int J Chron Obstruct Pulmon Dis. 2015 Aug 18;10:1663-72. doi: 10.2147/COPD.S82408. eCollection 2015.
9
The impact of heart failure and chronic obstructive pulmonary disease on mortality in patients presenting with breathlessness.心力衰竭和慢性阻塞性肺疾病对呼吸困难患者死亡率的影响。
Clin Res Cardiol. 2019 Feb;108(2):185-193. doi: 10.1007/s00392-018-1342-z. Epub 2018 Aug 8.
10
Cardiovascular Outcomes and All-Cause Mortality in Patients with Obstructive Sleep Apnea and Chronic Obstructive Pulmonary Disease (Overlap Syndrome).阻塞性睡眠呼吸暂停和慢性阻塞性肺疾病(重叠综合征)患者的心血管结局和全因死亡率。
Ann Am Thorac Soc. 2019 Jan;16(1):71-81. doi: 10.1513/AnnalsATS.201802-136OC.

引用本文的文献

1
Risk factors for mortality in Finnish bronchiectasis patients: A four-year study.芬兰支气管扩张症患者的死亡风险因素:一项为期四年的研究。
Chron Respir Dis. 2025 Jan-Dec;22:14799731251358596. doi: 10.1177/14799731251358596. Epub 2025 Aug 17.
2
Abnormally high exertional breathlessness predicts mortality in people referred for incremental cycle exercise testing.异常高的运动性呼吸困难预示着接受递增式循环运动测试者的死亡率。
PLoS One. 2024 Dec 18;19(12):e0302111. doi: 10.1371/journal.pone.0302111. eCollection 2024.
3
Exertional breathlessness related to medical conditions in middle-aged people: the population-based SCAPIS study of more than 25,000 men and women.

本文引用的文献

1
The 2017 Global Initiative for Chronic Obstructive Lung Disease Report and Practice Implications for the Respiratory Therapist.《2017年慢性阻塞性肺疾病全球倡议报告及对呼吸治疗师的实践意义》
Respir Care. 2017 Nov;62(11):1492-1500. doi: 10.4187/respcare.05402. Epub 2017 Sep 5.
2
Prognostic Importance of Dyspnea for Cardiovascular Outcomes and Mortality in Persons without Prevalent Cardiopulmonary Disease: The Atherosclerosis Risk in Communities Study.无心血管疾病病史人群中呼吸困难对心血管结局和死亡率的预后重要性:社区动脉粥样硬化风险研究
PLoS One. 2016 Oct 25;11(10):e0165111. doi: 10.1371/journal.pone.0165111. eCollection 2016.
3
与中年人群相关的与医学条件相关的运动性呼吸困难:超过 25000 名男性和女性的基于人群的 SCAPIS 研究。
Respir Res. 2024 Mar 16;25(1):127. doi: 10.1186/s12931-024-02766-6.
4
Associations in Perceived Health and Persistent Breathlessness: A Cross-Sectional Study.感知健康与持续性呼吸急促的关联:一项横断面研究。
Palliat Med Rep. 2023 Apr 20;4(1):120-126. doi: 10.1089/pmr.2022.0071. eCollection 2023.
5
Respiratory symptoms and cardiovascular causes of deaths: A population-based study with 45 years of follow-up.呼吸系统症状与心血管疾病死因:一项具有 45 年随访的基于人群的研究。
PLoS One. 2022 Oct 20;17(10):e0276560. doi: 10.1371/journal.pone.0276560. eCollection 2022.
6
Prognostic value of lymphocyte count for in-hospital mortality in patients with severe AECOPD.淋巴细胞计数对重症 AECOPD 患者住院死亡率的预测价值。
BMC Pulm Med. 2022 Oct 5;22(1):376. doi: 10.1186/s12890-022-02137-1.
7
Risk Factors for Postoperative Pneumonia: A Case-Control Study.术后肺炎的危险因素:病例对照研究。
Front Public Health. 2022 Jul 8;10:913897. doi: 10.3389/fpubh.2022.913897. eCollection 2022.
8
Comparing recalled versus experienced symptoms of breathlessness ratings: An ecological assessment study using mobile phone technology.比较回忆性和体验性呼吸困难症状评分:使用移动电话技术的生态评估研究。
Respirology. 2022 Oct;27(10):874-881. doi: 10.1111/resp.14313. Epub 2022 Jun 13.
9
Prevalence and severity of differing dimensions of breathlessness among elderly males in the population.人群中老年男性不同维度呼吸困难的患病率及严重程度。
ERJ Open Res. 2021 Feb 7;8(1). doi: 10.1183/23120541.00553-2021. eCollection 2022 Jan.
10
Agreement of the modified Medical Research Council and New York Heart Association scales for assessing the impact of self-rated breathlessness in cardiopulmonary disease.改良版医学研究委员会和纽约心脏协会量表在评估自我报告的呼吸困难对心肺疾病影响方面的一致性。
ERJ Open Res. 2022 Jan 24;8(1). doi: 10.1183/23120541.00460-2021. eCollection 2022 Jan.
Dyspnea as an independent predictor of mortality.
呼吸困难作为死亡率的独立预测因素。
Clin Respir J. 2016 Mar;10(2):142-52. doi: 10.1111/crj.12191. Epub 2014 Aug 20.
4
Predictors of dyspnoea prevalence: results from the BOLD study.呼吸困难患病率的预测因素:BOLD研究结果
Eur Respir J. 2014 Jun;43(6):1610-20. doi: 10.1183/09031936.00036813. Epub 2013 Oct 31.
5
Validation of a COPD diagnosis from the Swedish Inpatient Registry.从瑞典住院患者登记处验证 COPD 诊断。
Scand J Public Health. 2012 Dec;40(8):773-6. doi: 10.1177/1403494812463172. Epub 2012 Oct 19.
6
Dyspnea severity, changes in dyspnea status and mortality in the general population: the Vlagtwedde/Vlaardingen study.呼吸困难严重程度、呼吸困难状态变化与一般人群死亡率:弗拉格韦德/弗拉尔丁恩研究。
Eur J Epidemiol. 2012 Nov;27(11):867-76. doi: 10.1007/s10654-012-9736-0. Epub 2012 Oct 7.
7
An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea.美国胸科学会官方声明:呼吸困难机制、评估和管理的更新。
Am J Respir Crit Care Med. 2012 Feb 15;185(4):435-52. doi: 10.1164/rccm.201111-2042ST.
8
An algorithmic approach to chronic dyspnea.一种慢性呼吸困难的算法方法。
Respir Med. 2011 Jul;105(7):1014-21. doi: 10.1016/j.rmed.2010.12.009. Epub 2011 Jan 7.
9
Evaluation of dyspnoea in a sample of elderly subjects recruited from general practice.对从全科医疗招募的老年受试者样本中的呼吸困难情况进行评估。
Int J Clin Pract. 2007 Sep;61(9):1481-91. doi: 10.1111/j.1742-1241.2007.01428.x.
10
Breathlessness, phlegm and mortality: 26 years of follow-up in healthy middle-aged Norwegian men.呼吸急促、痰液与死亡率:对挪威健康中年男性的26年随访研究
J Intern Med. 2006 Oct;260(4):332-42. doi: 10.1111/j.1365-2796.2006.01693.x.